期刊文献+

支气管哮喘患者血浆TNF-α、IL-6和NT-proBNP的临床意义 被引量:17

Clinical significance of detection of TNF-α,IL-6,and NT-proBNP levels in patients with acute bronchial asthma
下载PDF
导出
摘要 目的探讨支气管哮喘急性发作患者血浆TNF-α、IL-6和NT-proBNP的临床意义。方法采用RIA、荧光免疫分析和超敏免疫分析分别检测63例支气管哮喘急性发作患者的TNF-α、IL-6和NT-proBNP,并与42例对照组进行比较。结果63例支气管哮喘急性发作患者血浆TNF-α和IL-6、NT-proBNP水平较42例对照组明显增高(P均<0.01),治疗后症状缓解期,TNF-α和IL-6、NT-proBNP水平呈逐步下降,其中TNF-α和IL-6水平在症状缓解半月后与对照组比较无显著差异(P均>0.05)。结论血浆TNF-α、IL-6和NT-proBNP是支气管哮喘患者急性发作及治疗后缓解的有价值的指标。 Objective To explore the clinical significance of detection of TNF-a, IL-6, and NT-pmBNP levels in patients with acute bronchial asthma. Methods 63 patients with acute bronchial asthma were selected as the experiment group and 42 healthy people were taken as the control group. The levels of TNF-a, IL-6, and NT-proBNP were detected by radioimmunoassay (RIA), fluorescence immunoassay and super-sensitivity immunoassay respectively. Then the results were compared. Results The levels of TNF-a and IL-6 were significantly higher in the experiment group than in the controls ( P 〈0. 01 ). After the inhalation of glucocorticoid, the levels of TNF-a and IL-6 still increased significantly ( P 〈 0.05 ), and half month after, the levels were back to normal value. Conclusion The levels of TNF-a, IL-6, and NT-proBNP can be used as a valuable index to evaluate the curative effect of glucocorticoid inhalation in the treatment of patients with acute bronchial asthma.
作者 徐莉 杨永青
出处 《临床肺科杂志》 2013年第2期292-293,共2页 Journal of Clinical Pulmonary Medicine
关键词 支气管哮喘 肿瘤坏死因子-Α 白介素-6 N氨基末端脑钠肽前体 acute bronchial asthma tumor necrosis factory-a interleukin-6, N-terminal pro-brain natriuretie peptide
  • 相关文献

参考文献8

二级参考文献29

  • 1赵雪燕,杨跃进,张健,党爱民,倪新海,黄洁,康晟,马卫华,赵冬云.B型利钠肽在诊断左心衰竭中的价值[J].中华医学杂志,2006,86(17):1165-1169. 被引量:97
  • 2赵明宝,王士富,范勇.内皮素与慢性肺原性心脏病的关系探讨[J].中国实用内科杂志,1997,17(3):168-168. 被引量:15
  • 3McGeoch G,Lainchbury J,Town GI,et al.Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice.Eur J Heart Fail,2002,4:479-483.
  • 4Tang WH,Girod JP,Lee MJ,et al.Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.Circulation,2003,16:2964-2966.
  • 5Vanderheyden M,Vrints C,Verstreken S,et al.B-type natriuretic peptide as a marker of heart failure:new insights from biochemistry and clinical implications.Biomark Med,2010,4:315-320.
  • 6Mohammed SF,Korinek J,Chen HH,et al.Nesiritide in acute decompensated heart failure:current status and future perspectives.Rev Cardiovasc Med,2008,9:151-158.
  • 7Miller WL,Burnett JC Jr,Hartman KA,et al.Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in severe heart failure patients treated with nesiritide.Am J Cardiol,2005,15:837-841.
  • 8Sun T,Wang L,Zhang Y.Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure.Intern Med J,2007,37:168-171.
  • 9Niederkofler EE,Kiernan UA,ORear J,et al.Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.Circ Heart Fail,2008,1:258-264.
  • 10Cohen-Solal A,Logeart D,Huang B,et al.Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.J Am Coll Cardiol,2009,53:2343-2348.

共引文献2582

同被引文献157

引证文献17

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部